OliX Pharmaceuticals, Inc (KOSDAQ:226950)
131,700
+9,300 (7.60%)
Jun 9, 2026, 3:30 PM KST
167.96% (1Y)
| Market Cap | 2.48T +193.6% |
| Revenue (ttm) | 17.26B +193.3% |
| Net Income | -12.25B |
| EPS | -596.25 |
| Shares Out | 20.30M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 281,710 |
| Open | 123,500 |
| Previous Close | 122,400 |
| Day's Range | 118,000 - 136,500 |
| 52-Week Range | 34,500 - 217,000 |
| Beta | 0.34 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |